| Primary |
| Drug Use For Unknown Indication |
28.6% |
| Product Used For Unknown Indication |
11.4% |
| Poisoning |
10.0% |
| Tremor |
8.6% |
| Schizophrenia |
7.1% |
| Adverse Event |
4.3% |
| Agitation |
4.3% |
| Extrapyramidal Disorder |
4.3% |
| Blood Pressure Increased |
2.9% |
| Mental Disorder |
2.9% |
| Poisoning Deliberate |
2.9% |
| Anxiety |
1.4% |
| Bipolar Disorder |
1.4% |
| Completed Suicide |
1.4% |
| Condition Aggravated |
1.4% |
| Dystonia |
1.4% |
| Gastric Disorder |
1.4% |
| Hyperhidrosis |
1.4% |
| Overdose |
1.4% |
| Pain |
1.4% |
|
| Completed Suicide |
10.3% |
| Rash |
10.3% |
| Hallucination, Visual |
6.9% |
| Ileus Paralytic |
6.9% |
| Sinus Tachycardia |
6.9% |
| Tremor |
6.9% |
| Vasculitic Rash |
6.9% |
| Adverse Drug Reaction |
3.4% |
| Bladder Dilatation |
3.4% |
| Catatonia |
3.4% |
| Confusional State |
3.4% |
| Constipation |
3.4% |
| Death |
3.4% |
| Delirium |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Drug Ineffective |
3.4% |
| Drug Interaction |
3.4% |
| Drug Toxicity |
3.4% |
| Dry Mouth |
3.4% |
| Dysuria |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
37.5% |
| Drug Use For Unknown Indication |
14.1% |
| Agitation |
7.9% |
| Schizophrenia |
6.4% |
| Psychotic Disorder |
5.4% |
| Suicide Attempt |
5.4% |
| Anxiety |
4.0% |
| Rheumatoid Arthritis |
3.0% |
| Extrapyramidal Disorder |
2.8% |
| Akathisia |
1.7% |
| Bipolar Disorder |
1.7% |
| Hallucination |
1.6% |
| Schizoaffective Disorder |
1.5% |
| Ill-defined Disorder |
1.1% |
| Mania |
1.1% |
| Prophylaxis |
1.1% |
| Depression |
1.0% |
| Muscle Relaxant Therapy |
1.0% |
| Restless Legs Syndrome |
0.9% |
| Tourette's Disorder |
0.9% |
|
| Completed Suicide |
22.7% |
| Ileus Paralytic |
16.7% |
| Toxicity To Various Agents |
6.7% |
| Psychotic Disorder |
5.3% |
| Vomiting |
5.3% |
| Death |
4.0% |
| Medication Error |
4.0% |
| Pneumonia |
4.0% |
| Treatment Noncompliance |
3.3% |
| Weight Increased |
3.3% |
| Colitis Ischaemic |
2.7% |
| Drug Toxicity |
2.7% |
| Renal Failure Acute |
2.7% |
| Respiratory Arrest |
2.7% |
| Serotonin Syndrome |
2.7% |
| Sinus Tachycardia |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
| Abdominal Pain |
2.0% |
| Loss Of Consciousness |
2.0% |
| Overdose |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.2% |
| Schizophrenia |
15.7% |
| Bipolar Disorder |
10.7% |
| Drug Use For Unknown Indication |
9.5% |
| Depression |
7.9% |
| Schizoaffective Disorder |
7.1% |
| Pain |
3.9% |
| Anxiety |
3.6% |
| Schizophrenia, Paranoid Type |
3.1% |
| Psychotic Disorder |
2.8% |
| Diabetes Mellitus |
2.3% |
| Insomnia |
1.9% |
| Hypertension |
1.9% |
| Extrapyramidal Disorder |
1.7% |
| Agitation |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Sleep Disorder |
1.5% |
| Hepatitis C |
1.5% |
| Affective Disorder |
1.4% |
| Parkinson's Disease |
1.2% |
|
| Granulocytopenia |
21.6% |
| Type 2 Diabetes Mellitus |
13.1% |
| Weight Increased |
10.9% |
| Leukopenia |
6.7% |
| Death |
5.7% |
| Tremor |
4.0% |
| Somnolence |
3.8% |
| Vomiting |
3.6% |
| Weight Decreased |
3.6% |
| Suicidal Ideation |
3.4% |
| Vision Blurred |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
| Pulmonary Embolism |
2.8% |
| Tardive Dyskinesia |
2.8% |
| Diabetes Mellitus |
2.6% |
| Psychotic Disorder |
2.4% |
| Pyrexia |
2.0% |
| Mental Disorder |
1.8% |
| Myocardial Infarction |
1.8% |
| Visual Acuity Reduced |
1.8% |
|
| Interacting |
| Product Used For Unknown Indication |
25.0% |
| Anxiety |
10.0% |
| Bipolar I Disorder |
10.0% |
| Depression |
10.0% |
| Liver Disorder |
10.0% |
| Smoking Cessation Therapy |
10.0% |
| Tourette's Disorder |
10.0% |
| Extrapyramidal Disorder |
5.0% |
| Fear |
5.0% |
| Tachyphrenia |
5.0% |
|
| Bruxism |
16.7% |
| Depression |
16.7% |
| Drug Interaction |
16.7% |
| Fear |
16.7% |
| Pneumonia |
16.7% |
| Suicidal Ideation |
16.7% |
|
